G-POEM for Glycemic Control in Diabetic Gastroparesis
- Sponsor
- French Society of Digestive Endoscopy
- Study ID
- NCT06965543
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Gastroparesis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- Immediate G-POEM — PROCEDUREGastric POEM (G-POEM) performed under general anesthesia. A submucosal tunnel will be created along the greater curvature of the stomach to access the pyloric muscle under endoscopic vision. The pylorus will be incised at two locations with a dual myotomy between the 5 and 8 o'clock positions on the clock face
- Delayed G-POEM — PROCEDUREParticipants will receive standard medical treatment, including prokinetic agents, antiemetics (ondansetron 8 mg twice daily), nutritional support, and dietary counseling. Laxative treatments will be prescribed as needed. After three months, participants will undergo G-POEM as described above
Study Details
Gastroparesis, commonly caused by diabetes, affects 30-50% of diabetic individuals and complicates glycemic control due to its bidirectional relationship with blood glucose levels. Current treatments are often ineffective. G-POEM, a minimally invasive endoscopic technique, has demonstrated promising results in improving digestive symptoms, particularly in diabetic patients, with over 80% success. However, its impact on glycemic control has not yet been investigated, highlighting the need for further research.
Key Dates
- First listed
- May 11, 2025
- Start date
- Jul 31, 2025
- Status verified
- May 2025
- Primary completion
- Jul 31, 2027
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Experimental Group: Immediate G-POEM
- Active Comparator: Delayed G-POEM : Standard Treatment Followed by G-POEM at 3 Months
Primary Outcome Measure
Percentage of time spent in target glycemic range >10% [ Time Frame: 3 months after randomization ]
Related Studies
- Domperidone in Treating Patients With Gastrointestinal DisordersPHASE3 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- GI Neuromuscular Pathology Prospective RegistryRecruiting · Indiana University · Indianapolis, Indiana
- Gastroparesis Outcome Longitudinal Database Enrolled NumericallyRecruiting · University of Louisville · Louisville, Kentucky
- IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune NeuropathyRecruiting · University of Louisville · Louisville, Kentucky